I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
Nicholas R, Brooks D, Owen D, 2019, In Response to Letter from Fregonara et al. 2019., Mol Imaging Biol
et al., 2019, Epstein-barr virus and monoclonal gammopathy of clinical significance in autologous stem cell transplantation for multiple sclerosis., Clinical Infectious Diseases, Vol:69, ISSN:1058-4838, Pages:1757-1763
et al., 2019, Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials, Multiple Sclerosis Journal, Vol:25, ISSN:1352-4585, Pages:1462-1471
et al., 2019, Confirmation of specific binding of the 18 kDa translocator protein (TSPO) radioligand [18F]GE-180: a blocking study using XBD173 in multiple sclerosis normal appearing white and grey matter, Molecular Imaging and Biology, Vol:21, ISSN:1536-1632, Pages:935-944
et al., 2019, Soluble CD27 a biomarker of T cell activity in intrathecal inflammation in patients with relapsing-remitting multiple sclerosis, 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SAGE PUBLICATIONS LTD, Pages:110-111, ISSN:1352-4585